mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic...

8

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Upload: john-jacob

Post on 26-Jul-2016

217 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 2: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 3: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 4: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 5: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 6: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 7: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Page 8: Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

© 1993 Nature Publishing Group http://www.nature.com/naturegenetics

Διαθεματικη παιδιων του Α1

νικολίνα α1

σχολικος εκφοβισμος α1

Α1 ανακαλύπτοντας τις σφίγγες

Structural determinants of alternating (α1 → 4) and (α1 ... · consecutive ( α1 → 6) linkages were detected. Later on, the oligosaccharides produced by GTFA also were isolated

Mάης ;Aνοιξη α1

παρουσίαση α1, α2

Aρχαϊκή εποχή (α1.πολιτική)

Παρουσιαση α1 2 Συντεταγμενες

α1 χριστουγεννιάτικες-ζωγραφιές

ευχές (τμήμα Α1)

CASE REPORT Familiar Hyperekplexia, a Potential Cause of … · 2019. 9. 4. · Hyperekplexia with Cautious Gait Lee Y, et al. 55 and ARHGEF9.The change in the patient’s GLRA1 sequence

ΠΑΣΧΑ 2011-Α1, Α2

Γραμματική (επίπεδο Α1)

σωστη διατροφη σοφ.αστ.(α1)

Hearing on Medical Marijuana (July 13, 2016) Daniele ......2016/07/13 · receptor, the transient receptor potential vanilloid type-1 channel, the α3 and α1 glycine receptors, the

Παρουσίαση 1 (Α1)

A. ΓΕΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ Α1. Προσωπικά Στοιχείαa. ΓΕΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ Α1. Προσωπικά Στοιχεία Οικογ 0ν 0ιακή

α1 στεφανι

Ελληνιστική εποχή (α1.πολιτική)

Α1. ΕΥΘΥΓΡΑΜΜΕΣ ΚΙΝΗΣΕΙΣ

Περιγραφή εξετάσεων: επίπεδο Α1 (Α1 /Α1/Α1+) 126_Beispiele.pdf · Σε μία σχολική εφημερίδα διαβάζεις το ακόλουθο

προτζεκτ α1 2ο τετραμηνο

Παρουσίαση Α1, Α2

GLYCINE METABOLISM

Κατερίνα Ερμείδου Α1

New potential therapeutic applications for certain ...cannabis-med.org/members/wp-content/uploads/2015/11/Pertwee.pdf · ion channels glycine α1, α1 β1 (↑) 5-HT 3A (-) Cation

technology report HTA α1-Proteinase Inhibitor for Patients ...Title: Human α1-Proteinase Inhibitor for Patients with α1-Antitrypsin Deficiency Date: December 12, 2005 Context and

No Slide Title - Edwards 103116.pdfDeletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40, 797-806. Guan, L., and Kaback,

Α1-Α3, ΟΔΥΣΣΕΙΑ, ΠΡΟΟΙΜΙΟ, α1-25

Late-onsetstartle syndrome and obsessive compulsive disorder · 2019. 8. 1. · Startle disease or hyperekplexia, Brain 103 (1980), 985–997. [3] Andrews and Owen, Hyperekplexia: